Table 1.
Cancer type | Male average incidence rates | Female average incidence rates | Male:female incidence ratio |
---|---|---|---|
Oropharynx and tonsil | 4.18 | 0.86 | 4.86 |
Larynx | 5.2 | 1.1 | 4.73 |
Esophagus | 7.34 | 1.74 | 4.22 |
Urinary Bladder | 35.24 | 8.74 | 4.03 |
Mesothelioma | 1.58 | 0.4 | 3.95 |
Lip | 1.02 | 0.32 | 3.19 |
Liver and intrahepatic bile duct | 13.58 | 4.72 | 2.88 |
Tongue | 5.22 | 1.92 | 2.72 |
Oral cavity and pharynx | 17.02 | 6.38 | 2.67 |
Floor of mouth | 0.68 | 0.3 | 2.27 |
Kidney and renal pelvis | 22.16 | 10.92 | 2.03 |
Myelodysplastic syndromes | 6.2 | 3.26 | 1.9 |
Stomach | 10 | 5.36 | 1.87 |
Salivary gland | 1.7 | 1.02 | 1.67 |
Leukemia | 18.06 | 10.9 | 1.66 |
Melanoma of the skin | 28.78 | 17.46 | 1.65 |
Myeloma | 8.7 | 5.58 | 1.56 |
Non-Hodgkin lymphoma | 23.9 | 16.22 | 1.47 |
Gum and other mouth | 1.84 | 1.28 | 1.44 |
Soft tissue including heart | 4.14 | 2.92 | 1.42 |
Brain and nervous system | 7.52 | 5.36 | 1.4 |
Small intestine | 2.74 | 2.06 | 1.33 |
Eye and orbit | 1.02 | 0.78 | 1.31 |
Colon and rectum | 44.28 | 33.98 | 1.3 |
Lung and bronchus | 63.08 | 48.94 | 1.29 |
Pancreas | 14.66 | 11.48 | 1.28 |
Hodgkin lymphoma | 3 | 2.38 | 1.26 |
Anorectal | 1.56 | 2.22 | 0.7 |
Gallbladder | 0.9 | 1.5 | 0.6 |
Thyroid | 8.04 | 23.26 | 0.35 |
Breast | 1.24 | 127.5 | 0.01 |
Incidence rates were calculated by averaging age-adjusted incidence rates per 100,000 from the last 5 years (2012–2016). Male:female ratio was calculated by dividing the male incidence rate by the female incidence rate, both shown in the table. The geometric mean of the male/female incidence ratio is 1.5